Joseph Jorge Loureiro
Research Subjects
Joseph Jorge Loureiro has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Keith O. Elliston
Rutgers University
2 shared publications - Andrea L Matthews
Genstruct, Inc., One Alewife Center, Cambridge, MA 02140, USA
1 shared publication Anupama Bhimavarapu
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
1 shared publication- Catherine Ellis
GSK, Collegeville, USA
1 shared publication Christian Reich
Genstruct Inc., One Alewife Center, Cambridge, Massachusetts, USA
1 shared publicationDaniel Maes
The Estee Lauder Companies, Melville, New York, USA
1 shared publication
Latest Publications
- Open Access
- 6 July 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 419
Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693
Inappropriate activation of AKT signaling is a relatively common occurrence in human tumors, and can be caused by activation of components of, or by loss or decreased activity of inhibitors of, this signaling pathway. A novel, pan AKT kinase inhibitor, GSK690693, was developed in order to interfere with the inappropriate AKT signaling seen in these human malignancies. Causal network modeling is a systematic computational analysis that identifies upstream changes in gene regulation that can serve as explanations for observed changes in gene expression. In this study, causal network modeling is employed to elucidate mechanisms of action of GSK690693 that contribute to its observed biological effects. The mechanism of action of GSK690693 was evaluated in multiple human tumor cell lines from different tissues in 2-D cultures and xenografts using RNA expression and phosphoproteomics data. Understanding the molecular mechanism of action of novel targeted agents can enhance our understanding of various biological processes regulated by the intended target and facilitate their clinical development.
- 6 July 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 419
Open AccessCausal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693
Inappropriate activation of AKT signaling is a relatively common occurrence in human tumors, and can be caused by activation of components of, or by loss or decreased activity of inhibitors of, this signaling pathway. A novel, pan AKT kinase inhibitor, GSK690693, was developed in order to interfere with the inappropriate AKT signaling seen in these human malignancies. Causal network modeling is a systematic computational analysis that identifies upstream changes in gene regulation that can serve as explanations for observed changes in gene expression. In this study, causal network modeling is employed to elucidate mechanisms of action of GSK690693 that contribute to its observed biological effects. The mechanism of action of GSK690693 was evaluated in multiple human tumor cell lines from different tissues in 2-D cultures and xenografts using RNA expression and phosphoproteomics data. Understanding the molecular mechanism of action of novel targeted agents can enhance our understanding of various biological processes regulated by the intended target and facilitate their clinical development.
- 1 January 2009
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (1) , 41-49
SIRT1 Promotes Differentiation of Normal Human Keratinocytes
- 1 January 2009
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (1) , 41-49
SIRT1 Promotes Differentiation of Normal Human Keratinocytes